
TGH BRINGS TOGETHER A CROSS DISCIPLINARY SENIOR INSTITUTIONAL AND RELATIONSHIP TEAM THAT IS PASSIONATE ABOUT ITS MISSION FOCUSED ON ENGINEERING AND PRODUCT EXCELLENCE
MANAGEMENT
Director & Chairman
ANTANAS ‘TONY’ GUOGA
Businessperson and Entrepreneur (founder, builder, investor, multiple exits).
Sports risks (including poker) hobbyist and investor. Strong interests in health-span and longevity.
Director, CEO & Interim CFO
R. RON AKRAM
Founder, Operator & CIO. Venture & PE Investor. LP in Pharma and Technology Companies. Hedge Fund / Asset Manager (Digital/Crypto Assets 'market neutral' & global macro 'directional').
Structuring Banker (Public & Private Markets, Cross Asset). Attorney (England & Wales; New York).
London Business School (Lecturer, Finance Faculty). Life-long Athlete & Longevity Enthusiast.
Director, Company Secretary & Audit Committee
GEDIMINAS KLEPACKAS
Seasoned executive with expertise in guiding company strategy and overseeing management teams, ensuring alignment with long-term objectives and regulatory compliance.
Extensive background in mergers and acquisitions, leading high-impact transactions focused on maximizing shareholder value and driving sustainable growth.
Deep knowledge of the blockchain and cryptocurrency sectors, offering insights into emerging technologies to enhance investment strategies and foster portfolio innovation.
Independent Director & Audit Committee
PETER TUTLYS
Brand & Business Operations Leader – 2 continents, 8 countries. Investor, Board Member, Strategy & Marketing Executive Suite.
Proven track record of profit and volume growth on Start-up and billion dollar portfolios. Pharma, Financial, Digital & Leisure sector exposure (Nike, Royal Bank Canada, GlaxoSmithKline).
University of Toronto (Economics), Business School lecturer.
Independent Director
BRIAN MEHLER
Private Equity interests spanning health infrastructure assets.
Comptroller
DOUGLAS HARRIS CA, CBV
30 years experience in financial markets, including buy-side,
sell-side and accounting.